Anzeige
Mehr »
Freitag, 06.06.2025 - Börsentäglich über 12.000 News
Starke Zahlen: EBITDA bei 9 Mio.?€ - Startet jetzt die Neubewertung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ALU7 | ISIN: US1266541028 | Ticker-Symbol:
Branche
Konsumgüter
Aktienmarkt
Sonstige
1-Jahres-Chart
CV SCIENCES INC Chart 1 Jahr
5-Tage-Chart
CV SCIENCES INC 5-Tage-Chart

Aktuelle News zur CV SCIENCES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CV SCIENCES Aktie jetzt für 0€ handeln
DoCV Sciences, Inc. - 8-K, Current Report-
14.05.CV Sciences targets cost efficiency gains and product diversification with in-source manufacturing and non-cannabinoid launches2
14.05.CV Sciences, Inc. - 10-Q, Quarterly Report1
14.05.CV Sciences, Inc. Reports First Quarter 2025 Financial Results246SAN DIEGO, CA / ACCESS Newswire / May 14, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
14.05.CV Sciences, Inc. - 8-K, Current Report3
10.05.CV Sciences, Inc. to Announce First Quarter 2025 Results on May 14, 2025335SAN DIEGO, CA / ACCESS Newswire / May 9, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
28.03.CV Sciences, Inc. (PNK:CVSI) Q4 2024 Earnings Call Transcript1
27.03.CV Sciences, Inc. - 10-K, Annual Report1
27.03.CV Sciences targets profitability with new product lines and M&A strategy in 20253
27.03.CV Sciences, Inc. - 8-K, Current Report2
27.03.CV Sciences Non-GAAP EPS of -$0.01, revenue of $15.71M3
27.03.CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results421SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts...
► Artikel lesen
26.03.CV Sciences debuts Lunar Fox plant-based food line1
26.03.CV Sciences startet pflanzliche Lebensmittellinie Lunar Fox2
26.03.CV Sciences, Inc.: CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods833The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CVSI)...
► Artikel lesen
20.03.CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025278SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in...
► Artikel lesen
20.02.CV Sciences, Inc. - 8-K, Current Report-
11.02.CV Sciences, Inc. - 8-K, Current Report-
05.02.CV Sciences, Inc.: CV Sciences Unveils New Aura Collection THC Fizz Tablets190The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025...
► Artikel lesen
21.11.24CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs144SAN DIEGO, Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company...
► Artikel lesen
Weiter >>
22 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1